Single QSR Subsystem Failure Will Lead To Regulatory Action, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers with a quality system subsystem failure will be given "official action indicated" status and face FDA regulatory action under the agency's proposed QS inspection technique policy, FDA's Good Manufacturing Practices/Quality System Expert Kim Trautman said.